NASDAQ : ASMB
Assembly Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 20.13 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 409.86M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Assembly Biosciences, Inc. (ASMB) reported revenue of 74.84M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 74.84M | 72.30M | 28.52M | 7.16M | 6.25M | |
| Cost of Revenue | 63.65M | 64.81M | 55.93M | 48.90M | 69.08M | 70.15M |
| Gross Profit | 11.19M | 7.49M | -27.41M | -41.74M | -69.08M | -63.90M |
| Selling, General & Admin | 19.99M | 19.61M | 18.01M | 22.91M | 23.93M | 28.50M |
| Operating Expenses | 19.99M | 19.61M | 18.01M | 22.91M | 23.93M | 28.50M |
| Operating Income | -8.80M | -12.12M | -45.42M | -64.65M | -93.01M | -92.40M |
| Interest & Investment Income | 8.76M | 6.00M | 5.57M | 3.45M | 1.02M | 302.00K |
| EBT Excluding Unusual Items | -42.00K | -6.12M | -39.85M | -61.20M | -91.99M | -92.10M |
| Merger & Restructuring Charges | -1.10M | 1.35M | ||||
| Impairment of Goodwill | -12.60M | |||||
| Asset Writedown | -38.00K | |||||
| Pretax Income | -42.00K | -6.12M | -39.85M | -61.20M | -93.09M | -132.39M |
| Income Tax Expense | 330.00K | 33.00K | -2.53M | |||
| Net Income | -42.00K | -6.12M | -40.18M | -61.23M | -93.09M | -129.85M |
| Net Income to Common | -42.00K | -6.12M | -40.18M | -61.23M | -93.09M | -129.85M |
| Shares Outstanding (Basic) | 16.36M | 11.21M | 6.00M | 4.58M | 4.03M | 3.61M |
| Shares Outstanding (Diluted) | 16.36M | 11.21M | 6.00M | 4.58M | 4.03M | 3.61M |
| EPS (Basic) | -0.00 | -0.55 | -6.69 | -13.38 | -23.08 | -36.00 |
| EPS (Diluted) | -0.00 | -0.55 | -6.69 | -13.38 | -23.08 | -36.00 |
| Free Cash Flow | -38.57M | -41.16M | -51.15M | 22.49M | -84.56M | -96.49M |
| Free Cash Flow Per Share | -2.36 | -3.67 | -8.52 | 4.91 | -20.96 | -26.75 |
| Gross Margin | 14.95% | 10.36% | -96.12% | |||
| Operating Margin | -11.76% | -16.76% | -159.26% | -902.50% | -1,477.42% | |
| Profit Margin | -0.06% | -8.47% | -140.87% | -854.78% | -2,076.35% | |
| Free Cash Flow Margin | -51.53% | -56.93% | -179.33% | 313.95% | -1,542.88% | |
| EBITDA | -8.69M | -11.99M | -45.29M | -64.20M | -92.52M | -91.93M |
| EBITDA Margin | -11.61% | -16.58% | -158.80% | |||
| D&A For EBITDA | 110.00K | 129.00K | 129.00K | 450.00K | 498.00K | 466.00K |
| EBIT | -8.80M | -12.12M | -45.42M | -64.65M | -93.01M | -92.40M |
| EBIT Margin | -11.76% | -16.76% | -159.26% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 32.29M | 58.45M | 38.34M | 19.84M | 52.42M | 45.63M |
| Short-Term Investments | 288.07M | 189.66M | 73.73M | 110.41M | 39.19M | 101.00M |
| Cash & Short-Term Investments | 320.36M | 248.11M | 112.08M | 130.25M | 91.61M | 146.63M |
| Accounts Receivable | 822.00K | 974.00K | 43.00K | 944.00K | 336.00K | |
| Other Receivables | 2.10M | 1.50M | 400.00K | 300.00K | 300.00K | |
| Receivables | 2.92M | 2.47M | 400.00K | 343.00K | 1.24M | 336.00K |
| Prepaid Expenses | 4.70M | 3.97M | 3.02M | 3.20M | 4.11M | 7.24M |
| Total Current Assets | 327.98M | 254.55M | 115.50M | 133.79M | 96.97M | 154.20M |
| Property, Plant & Equipment | 2.54M | 2.73M | 3.35M | 2.72M | 3.94M | 7.18M |
| Long-Term Investments | 27.97M | |||||
| Long-Term Deferred Charges | 200.00K | 200.00K | ||||
| Other Long-Term Assets | 312.00K | 312.00K | 312.00K | 312.00K | 689.00K | 1.50M |
| Total Assets | 330.83M | 257.59M | 119.17M | 136.82M | 101.79M | 191.06M |
| Accounts Payable | 1.18M | 1.17M | 585.00K | 461.00K | 2.49M | 2.66M |
| Accrued Expenses | 5.35M | 10.14M | 9.13M | 6.63M | 9.84M | 10.26M |
| Current Portion of Leases | 612.00K | 569.00K | 461.00K | 1.22M | 3.36M | 3.15M |
| Current Unearned Revenue | 16.30M | 36.90M | 37.62M | 30.91M | ||
| Other Current Liabilities | 599.00K | |||||
| Total Current Liabilities | 23.45M | 48.78M | 47.80M | 39.23M | 16.30M | 16.07M |
| Long-Term Leases | 1.74M | 2.06M | 2.63M | 1.12M | 101.00K | 3.33M |
| Long-Term Unearned Revenue | 35.38M | 55.38M | 2.73M | 2.73M | ||
| Total Liabilities | 25.18M | 50.84M | 85.81M | 95.73M | 19.13M | 22.13M |
| Common Stock | 20.00K | 16.00K | 7.00K | 5.00K | 4.00K | 48.00K |
| Additional Paid-In Capital | 1.15B | 1.04B | 859.49M | 826.92M | 807.98M | 800.73M |
| Retained Earnings | -844.98M | -832.05M | -825.92M | -785.75M | -724.52M | -631.43M |
| Comprehensive Income & Other | -623.00K | -41.00K | -211.00K | -81.00K | -803.00K | -419.00K |
| Shareholders' Equity | 305.65M | 206.75M | 33.36M | 41.10M | 82.66M | 168.93M |
| Total Liabilities & Equity | 330.83M | 257.59M | 119.17M | 136.82M | 101.79M | 191.06M |
| Total Debt | 2.35M | 2.63M | 3.09M | 2.34M | 3.46M | 6.48M |
| Net Cash (Debt) | 318.01M | 245.48M | 108.99M | 127.91M | 88.14M | 168.12M |
| Net Cash Per Share | 19.44 | 21.90 | 18.15 | 27.94 | 21.85 | 46.61 |
| Filing Date Shares Outstanding | 20.36M | 15.86M | 7.50M | 5.48M | 4.33M | 4.01M |
| Total Common Shares Outstanding | 19.85M | 15.86M | 7.46M | 5.48M | 4.07M | 4.01M |
| Working Capital | 304.53M | 205.77M | 67.70M | 94.56M | 80.67M | 138.13M |
| Book Value Per Share | 15.40 | 13.04 | 4.47 | 7.50 | 20.29 | 42.13 |
| Tangible Book Value | 305.65M | 206.75M | 33.36M | 41.10M | 82.66M | 168.93M |
| Tangible Book Value Per Share | 15.40 | 13.04 | 4.47 | 7.50 | 20.29 | 42.13 |
| Machinery | 801.00K | 717.00K | ||||
| Leasehold Improvements | 1.63M | 1.63M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -42.00K | -6.12M | -40.18M | -61.23M | -93.09M | -129.85M |
| Depreciation & Amortization | 110.00K | 129.00K | 129.00K | 450.00K | 498.00K | 466.00K |
| Loss (Gain) From Sale of Assets | 139.00K | -1.38M | ||||
| Asset Writedown & Restructuring Costs | 41.64M | |||||
| Loss (Gain) From Sale of Investments | -3.02M | -2.35M | -3.66M | -1.58M | 155.00K | 586.00K |
| Stock-Based Compensation | 6.66M | 4.68M | 3.12M | 5.12M | 6.59M | 5.24M |
| Other Operating Activities | 820.00K | 851.00K | 1.42M | 3.51M | 3.50M | 1.31M |
| Change in Accounts Receivable | -822.00K | -974.00K | 43.00K | 901.00K | -608.00K | 894.00K |
| Change in Accounts Payable | 316.00K | 586.00K | 124.00K | -2.03M | -166.00K | -1.94M |
| Change in Unearned Revenue | -37.65M | -36.10M | -13.29M | 83.56M | -6.25M | |
| Change in Other Net Operating Assets | -4.86M | -1.79M | 1.18M | -6.09M | -1.35M | -4.10M |
| Operating Cash Flow | -38.48M | -41.09M | -51.12M | 22.74M | -84.46M | -93.40M |
| Capital Expenditures | -85.00K | -66.00K | -28.00K | -255.00K | -102.00K | -3.10M |
| Sale of Property, Plant & Equipment | 24.00K | 1.50M | 2.36M | |||
| Investment in Securities | -234.43M | -113.40M | 40.20M | -68.91M | 89.24M | 27.25M |
| Investing Cash Flow | -234.51M | -113.47M | 40.17M | -69.14M | 90.64M | 26.52M |
| Issuance of Common Stock | 281.27M | 174.67M | 29.45M | 13.82M | 614.00K | 53.06M |
| Financing Cash Flow | 281.27M | 174.67M | 29.45M | 13.82M | 614.00K | 53.06M |
| Net Cash Flow | 8.28M | 20.11M | 18.50M | -32.58M | 6.79M | -13.82M |
| Free Cash Flow | -38.57M | -41.16M | -51.15M | 22.49M | -84.56M | -96.49M |
| Free Cash Flow Margin | -51.53% | -56.93% | -179.33% | 313.95% | -1,542.88% | |
| Free Cash Flow Per Share | -2.36 | -3.67 | -8.52 | 4.91 | -20.96 | -26.75 |
| Levered Free Cash Flow | -27.87M | -4.98M | -15.71M | -8.20M | -48.91M | -62.75M |
| Unlevered Free Cash Flow | -27.87M | -4.98M | -15.71M | -8.20M | -48.91M | -62.75M |
| Cash Income Tax Paid | 400.00K | |||||
| Change in Working Capital | -43.01M | -38.28M | -11.95M | 76.34M | -2.12M | -11.40M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 409.86M | 537.94M | 100.30M | 53.96M | 63.41M | 111.52M |
| Enterprise Value | 91.85M | 308.14M | 6.79M | 8.67M | -40.95M | -71.33M |
| Last Close Price | 20.13 | 34.01 | 15.78 | 9.84 | 15.60 | 27.96 |
| PS Ratio | 5.48 | 7.44 | 3.52 | 7.53 | 17.83 | |
| PB Ratio | 1.31 | 2.60 | 3.01 | 1.31 | 0.77 | 0.66 |
| P/TBV Ratio | 1.34 | 2.60 | 3.01 | 1.31 | 0.77 | 0.66 |
| P/FCF Ratio | 2.40 | |||||
| P/OCF Ratio | 2.37 | |||||
| EV/Sales Ratio | 1.23 | 4.26 | 0.24 | 1.21 | ||
| EV/FCF Ratio | 0.39 | |||||
| Debt / Equity Ratio | 0.01 | 0.01 | 0.09 | 0.06 | 0.04 | 0.04 |
| Debt / FCF Ratio | 0.10 | |||||
| Net Debt / Equity Ratio | -1.04 | -1.19 | -3.27 | -3.11 | -1.07 | -0.99 |
| Net Debt / EBITDA Ratio | 36.60 | 20.48 | 2.41 | 1.99 | 0.95 | 1.83 |
| Net Debt / FCF Ratio | 8.25 | 5.96 | 2.13 | -5.69 | 1.04 | 1.74 |
| Asset Turnover | 0.36 | 0.38 | 0.22 | 0.06 | 0.03 | |
| Quick Ratio | 13.79 | 5.14 | 2.35 | 3.33 | 5.70 | 9.14 |
| Current Ratio | 13.99 | 5.22 | 2.42 | 3.41 | 5.95 | 9.59 |
| Return on Equity (ROE) | -0.03% | -5.10% | -107.92% | -98.95% | -74.00% | -63.42% |
| Return on Assets (ROA) | -2.67% | -4.02% | -22.18% | -33.87% | -39.70% | -24.35% |
| Return on Capital Employed (ROCE) | -2.90% | -5.80% | -63.60% | -66.20% | -108.80% | -52.80% |
| Earnings Yield | -0.01% | -1.14% | -40.06% | -113.47% | -146.80% | -116.44% |
| FCF Yield | -9.41% | -7.65% | -50.99% | 41.68% | -133.35% | -86.53% |
| Buyback Yield / Dilution | -133.27% | -86.71% | -31.18% | -13.47% | -11.85% | -22.17% |